Researchers at the University of Basel are able to test in parallel the effects of over 1500 active substances on cell metabolism.

The Veilguard's failure on a lack of a shared world, that raises questions about what EA will demand from Mass Effect 5.

Amid changes at BioWare as the studio shifts its focus to Mass Effect 5, while shuffling some devs to other EA studios and ...

The fifth entry in the Mass Effect series is reportedly still in production and on track despite recent layoffs and studio ...

BioWare general manager Gary McKay tried to explain the current state of the studio in a new blog post that was full of vague ...

The next Mass Effect game is still in the pre-production phase even if BioWare has been buzzing in the news lately with ...

Bausch Health's (BHC) Q4 results on Feb. 19 will be mainly eyed by investors for the company's 2025 Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 ...

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 19, 2025. Bausch Health will host a ...

Now that Dragon Age: The Veilguard has shipped and BioWare is free to pour its resources into the fifth entry in the Mass Effect series, players are naturally getting excited. But according to ...

As Mass Effect 2 celebrates its 15th anniversary, we look into why the new game is taking so long and whether it will ever be out. BioWare’s history is built on a wealth of critically-acclaimed ...

Bloomberg notes that the move aligns with the studio's statement last year that it would "loan out" some of its developers to other projects within its ...